(Q45958682)

18 December 2017

title

Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota. (English)

1 reference

18 December 2017

0 references

Sang-Hee Jeong

1

1 reference

18 December 2017

Yun-Kyung Song

series ordinal

2

1 reference

18 December 2017

Joon-Hyoung Cho

series ordinal

3

1 reference

18 December 2017

language of work or name

English

0 references

publication date

24 January 2009

1 reference

18 December 2017

Regulatory Toxicology and Pharmacology

published in

1 reference

18 December 2017

volume

53

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

209-216

1 reference

18 December 2017

Basis for the evaluation of the microbiological risks due to veterinary drug residues in food

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Are veterinary medicines causing environmental risks?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Influence of flavomycin on microbial numbers, microbial metabolism and gut tissue protein turnover in the digestive tract of sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Probiotics in man and animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Emerging mechanisms of fluoroquinolone resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

The effect of intramuscular administration of colistin on the development and course of experimentally induced oedema disease in weaned piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Minimal Antibiotic Concentrations of Aminoglycosides and -Lactam Antibiotics for Some Gram-Negative Bacilli and Gram-Positive Cocci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Health implications of residues of veterinary drugs and chemicals in animal tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Flavophospholipol use in animals: positive implications for antimicrobial resistance based on its microbiologic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.01.004

10.1016/J.YRTPH.2009.01.004

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017